PAPER Humpel C

Identifying and validating biomarkers for Alzheimer's disease.

Trends Biotechnol. 2011 Jan;29(1):26-32. PubMed.

PAPER Haupt C, Fändrich M

Biotechnologically engineered protein binders for applications in amyloid diseases.

Trends Biotechnol. 2014 Oct;32(10):513-20. Epub 2014 Aug 26 PubMed.

PAPER Aday S, Cecchelli R, Hallier-Vanuxeem D, Dehouck MP, Ferreira L

Stem Cell-Based Human Blood-Brain Barrier Models for Drug Discovery and Delivery.

Trends Biotechnol. 2016 May;34(5):382-93. Epub 2016 Feb 3 PubMed.

PAPER Hajipour MJ, Santoso MR, Rezaee F, Aghaverdi H, Mahmoudi M, Perry G

Advances in Alzheimer's Diagnosis and Therapy: The Implications of Nanotechnology.

Trends Biotechnol. 2017 Oct;35(10):937-953. Epub 2017 Jun 27 PubMed.

PAPER Wei TY, Fu Y, Chang KH, Lin KJ, Lu YJ, Cheng CM

Point-of-Care Devices Using Disease Biomarkers To Diagnose Neurodegenerative Disorders.

Trends Biotechnol. 2018 Mar;36(3):290-303. Epub 2017 Dec 11 PubMed.

PAPER Cattaneo A, Chirichella M

Targeting the Post-translational Proteome with Intrabodies.

Trends Biotechnol. 2019 Jun;37(6):578-591. Epub 2018 Dec 18 PubMed.

PAPER Soto C

α-Synuclein seed amplification technology for Parkinson's disease and related synucleinopathies.

Trends Biotechnol. 2024 Jul;42(7):829-841. Epub 2024 Feb 23 PubMed.

PAPER Holtzman DM, Fagan AM

Potential role of apoE in structural plasticity in the nervous system; implications for disorders of the central nervous system.

Trends Cardiovasc Med. 1998 Aug;8(6):250-5. PubMed.

PAPER Klezovitch O, Scanu AM

Domains of apolipoprotein E involved in the binding to the protein core of biglycan of the vascular extracellular matrix: potential relationship between retention and anti-atherogenic properties of this apolipoprotein.

Trends Cardiovasc Med. 2001 Oct;11(7):263-8. PubMed.

PAPER Saito T, Ishigaki Y, Oikawa S, Yamamoto TT

Etiological significance of apolipoprotein E mutations in lipoprotein glomerulopathy.

Trends Cardiovasc Med. 2002 Feb;12(2):67-70. PubMed.

PAPER Rothermel BA, Vega RB, Williams RS

The role of modulatory calcineurin-interacting proteins in calcineurin signaling.

Trends Cardiovasc Med. 2003 Jan;13(1):15-21. PubMed.

PAPER Jacobs V, Cutler MJ, Day JD, Bunch TJ

Atrial fibrillation and dementia.

Trends Cardiovasc Med. 2015 Jan;25(1):44-51. Epub 2014 Sep 16 PubMed.

PAPER Golive A, Jared Bunch T

Editorial Commentary: Are statins a solution to reduce the risk of cognitive decline or lower the risk of dementia?

Trends Cardiovasc Med. 2016 Aug;26(6):566-7. Epub 2016 Apr 27 PubMed.

PAPER Samaras K, Brodaty H, Sachdev PS

Does statin use cause memory decline in the elderly?

Trends Cardiovasc Med. 2016 Aug;26(6):550-65. Epub 2016 Mar 28 PubMed.

PAPER Wirak DO

Deposits of amyloid beta protein in the central nervous system of transgenic mice.

Trends Cell Biol. 1991 Oct;1(4):85. PubMed.